Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
13 August 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 478,342 | $4.00 | $1,913,368.00 | 5,806,670 |
13 August 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 21,658 | $4.00 | $86,632.00 | 252,858 |
2 January 2024 | John H TuckerPresident/CEO | Sell Tax related | 4,942 | $6.39 | $31,579.38 | 140,647 |
2 January 2024 | Rachael NokesCFO | Sell Tax related | 1,027 | $6.39 | $6,562.53 | 20,566 |
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
13 August 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 478,342 | $4.00 | $1,913,368.00 | 5,806,670 |
13 August 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 21,658 | $4.00 | $86,632.00 | 252,858 |
2 January 2024 | John H TuckerPresident/CEO | Sell Tax related | 4,942 | $6.39 | $31,579.38 | 140,647 |
2 January 2024 | Rachael NokesCFO | Sell Tax related | 1,027 | $6.39 | $6,562.53 | 20,566 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.